Have a personal or library account? Click to login
Secondary prevention of patients with ischaemic stroke after recanalization treatment Cover

Secondary prevention of patients with ischaemic stroke after recanalization treatment

European Pharmaceutical Journal
Volume 69 (2022): Issue s1 (July 2022)
By: Michaela Benesová,  Marek Krivošík,  Stanislava Kosírová and  Tatiana Foltánová  
Open Access
|Jul 2022

Figures & Tables

Figure 1

Average values of National Institute of Health Stroke Scale - NIHSS.
Average values of National Institute of Health Stroke Scale - NIHSS.

Figure 2

Important time attributes.
Important time attributes.

Figure 3

Pharmacotherapy, NSAIDS nonsteroidal antiinflammatory drugs, *p≤0.05.
Pharmacotherapy, NSAIDS nonsteroidal antiinflammatory drugs, *p≤0.05.

Figure 4

Antithrombotic therapy ASA - acetylasalicylic acid, NOACs - new oral anticoagulants.
Antithrombotic therapy ASA - acetylasalicylic acid, NOACs - new oral anticoagulants.
DOI: https://doi.org/10.2478/afpuc-2022-0013 | Journal eISSN: 2453-6725
Journal RSS Feed
Language: English
Page range: 79 - 81
Submitted on: Jun 4, 2022
|
Accepted on: Jun 6, 2022
|
Published on: Jul 13, 2022
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
ischaemic stroke,
secondary prevention,
antiplatelet therapy,
anticoagulant therapy,
intravenous thrombolysis
Related subjects:
Pharmacy,
Pharmacy, other

© 2022 Michaela Benesová, Marek Krivošík, Stanislava Kosírová, Tatiana Foltánová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 69 (2022): Issue s1 (July 2022)Next article